- Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes. Gynecologic Oncology. 2017 Academic Article GET IT
Weekly paclitaxel with intermittent imatinib mesylate (Gleevec®): Tolerance and activity in recurrent epithelial ovarian cancer.
Times cited: 12